Lopinavir and Ritonavir

Product NDC
33342-164
11-digit product format
333420164
Labeler code
33342
Product ID
33342-164_115178c8-5ee2-4d96-820e-ea8264c1ac10
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lopinavir and Ritonavir
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Macleods Pharmaceuticals Limited
Application
ANDA204739
Marketing category
ANDA
Marketing start
2024-07-25
Substance
LOPINAVIR; RITONAVIR
Active strength
200; 50 mg/1; mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Lopinavir and Ritonavir
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LOPINAVIR200 mg/1
RITONAVIR50 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiO3J8G9O825, 2494G1JF75
Rxcui597730, 746645

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1d2364f5-8b1e-7c9a-4518-7b359d95fa50Product name220250116
00d976a9-a12a-db3d-ac4e-27498af714cfProduct name520250115
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
7a5f5ac7-15c0-4d8b-bea4-b3b28cb83a8dProduct name120231023
594e2c86-3079-4e6e-96c9-48f7a8afc78dProduct name120230718
c8f34825-48cd-e7db-4048-c3be840a9308Product name520230123
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
d1ee4fdb-1116-417b-8889-dc05571445b3Product name120160825
f8d26468-b1dc-49d8-a188-8b5d531405efProduct name120150731
0b1bb9d1-e628-4e7c-aada-fd6532257932Product name120150416
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
96979b26-bb9a-43d8-e3a6-d69b9e9f75e5Product name120140508
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
33342-164-09Lopinavir and Ritonavir60 in 1 BOTTLETABLET, FILM COATED601

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
33342-164LOPINAVIR AND RITONAVIR TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED]1Current NDC, 1 package rows20240820_115178c8-5ee2-4d96-820e-ea8264c1ac10.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
746645lopinavir 100 MG / ritonavir 25 MG Oral TabletPSN115178c8-5ee2-4d96-820e-ea8264c1ac101
597730lopinavir 200 MG / ritonavir 50 MG Oral TabletPSN115178c8-5ee2-4d96-820e-ea8264c1ac101
746645lopinavir 100 MG / ritonavir 25 MG Oral TabletSCD115178c8-5ee2-4d96-820e-ea8264c1ac101
597730lopinavir 200 MG / ritonavir 50 MG Oral TabletSCD115178c8-5ee2-4d96-820e-ea8264c1ac101

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
33342-164-093334201640960 TABLET, FILM COATED in 1 BOTTLE (33342-164-09) 2024-07-25NoNoHistorical